Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

• Last SEC data release: 2026-03-13
• Last 15 days FTD volume: A$2.62 M
• Last 3 months FTD volume: A$14.11 M
• Last 12 months FTD volume: A$49.57 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	A$55.5 M	A$0.14 B	🇺🇸 USA
Pfizer PFE	A$45.54 M	A$0.11 B	🇺🇸 USA
Eli Lilly LLY	A$27.23 M	A$0.38 B	🇺🇸 USA
Sanofi SNY	A$1.29 M	A$70.46 M	🇫🇷 France
Baxter BAX	A$23.64 M	A$86.49 M	🇺🇸 USA
MannKind Corp MNKD	A$0.3 M	A$1.52 M	🇺🇸 USA